Proton pump inhibitors and Raynaud's phenomenon: is there a link?
作者信息
Khouri Charles, Revol Bruno, Cracowski Jean-Luc, Roustit Matthieu
机构信息
Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
Clinical Pharmacology Department, Grenoble Alpes University Hospital, Grenoble, France.
出版信息
Br J Clin Pharmacol. 2018 Oct;84(10):2443-2444. doi: 10.1111/bcp.13697. Epub 2018 Jul 12.
Abstract
摘要
相似文献
1
Proton pump inhibitors and Raynaud's phenomenon: is there a link?质子泵抑制剂与雷诺现象：存在关联吗？
Br J Clin Pharmacol. 2018 Oct;84(10):2443-2444. doi: 10.1111/bcp.13697. Epub 2018 Jul 12.
2
ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.小儿胃食管反流病的抗分泌治疗——一项系统评价
Arq Gastroenterol. 2017 Dec;54(4):271-280. doi: 10.1590/S0004-2803.201700000-42. Epub 2017 Sep 21.
3
Pregnancy and drugs used in gastro-oesophageal reflux.妊娠与用于胃食管反流的药物
Prescrire Int. 2015 Dec;24(166):297-9.
4
Study Questions Use of Acid Suppressors to Curb Mild Infant Reflux.关于使用抑酸剂抑制婴儿轻度反流的研究问题
JAMA. 2017 Oct 17;318(15):1427-1428. doi: 10.1001/jama.2017.12160.
5
Drugs for peptic ulcer disease and GERD.用于消化性溃疡疾病和胃食管反流病的药物。
Treat Guidel Med Lett. 2011 Sep;9(109):55-60; quiz 2 p following 60.
6
Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.儿童胃食管反流病治疗中报告的不良反应：一项10年的文献综述。
Br J Clin Pharmacol. 2015 Aug;80(2):200-8. doi: 10.1111/bcp.12619. Epub 2015 Jun 11.
7
Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it.婴儿抑酸药物的过度处方：其产生的原因、错误之处以及应对措施。
J Pediatr. 2012 Feb;160(2):193-8. doi: 10.1016/j.jpeds.2011.08.067. Epub 2011 Oct 22.
8
[Acid inhibition leads to vitamin b12 deficiency].酸抑制会导致维生素B12缺乏。
Med Monatsschr Pharm. 2014 May;37(5):190-1.
9
Drugs for GERD and peptic ulcer disease.用于治疗胃食管反流病和消化性溃疡病的药物。
Med Lett Drugs Ther. 2018 Jan 15;60(1538):9-16.
10
Comparison table: Drugs for GERD and peptic ulcer disease.比较表：用于胃食管反流病和消化性溃疡病的药物。
Med Lett Drugs Ther. 2018 Jan 15;60(1538):e16-e18.
本文引用的文献
1
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南：更新和扩展，以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.《药理学简明指南 2017/18：酶》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
3
Proton Pump Inhibitors Accelerate Endothelial Senescence.质子泵抑制剂加速内皮细胞衰老。
Circ Res. 2016 Jun 10;118(12):e36-42. doi: 10.1161/CIRCRESAHA.116.308807. Epub 2016 May 10.
4
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.质子泵抑制剂的使用与普通人群心肌梗死风险
PLoS One. 2015 Jun 10;10(6):e0124653. doi: 10.1371/journal.pone.0124653. eCollection 2015.
5
Proton pump inhibitor use represents an independent risk factor for myocardial infarction.使用质子泵抑制剂是心肌梗死的一个独立危险因素。
Int J Cardiol. 2014 Nov 15;177(1):292-7. doi: 10.1016/j.ijcard.2014.09.036. Epub 2014 Sep 28.
6
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.质子泵抑制剂的意外作用：心血管风险因素不对称二甲基精氨酸的升高。
Circulation. 2013 Aug 20;128(8):845-53. doi: 10.1161/CIRCULATIONAHA.113.003602. Epub 2013 Jul 3.
7
The pathogenesis, diagnosis and treatment of Raynaud phenomenon.雷诺现象的发病机制、诊断和治疗。
Nat Rev Rheumatol. 2012 Aug;8(8):469-79. doi: 10.1038/nrrheum.2012.96. Epub 2012 Jul 10.
8
Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.血浆非对称性二甲基精氨酸预测接受冠状动脉造影检查的个体的死亡和主要不良心血管事件。
Int J Cardiol. 2011 Dec 1;153(2):135-40. doi: 10.1016/j.ijcard.2011.06.120. Epub 2011 Jul 26.
9
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.使用比例报告比（PRR）从自发药物不良反应报告中生成信号。
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6. doi: 10.1002/pds.677.
Zotero 插件